Paper18157
Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers.
Bartsch W and 3 others. Arzneimittelforschung, 1977. Cited by 44 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers. Papers, record 18157. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18157
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic beta-Antagonists | Major topic |
| Carbazoles | Major topic |
| Heart | Major topic |
| Phenyl Ethers | Major topic |
| Propanolamines | Major topic |
| Animals | |
| Heart Rate | |
| Isoproterenol | |
| Lethal Dose 50 | |
| Mice | |
| Rabbits | |
| Rats | |
| Sympathomimetics |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34,088,840 | Visualization of β-adrenergic receptor dynamics and differential localization in cardiomyocytes. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34088840 | PubMed |
| 6,296,703 | Competitive and non-competitive interactions between specific ligands and beta-adrenoceptors in living cardiac cells. | Naunyn Schmiedebergs Arch Pharmacol | 1982 | https://conductscience.org/library/papers/6296703 | PubMed |
| 6,154,947 | Macromolecular beta-adrenergic antagonists discriminating between receptor and antibody. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6154947 | PubMed |
| 6,126,894 | Metipranolol and propranolol: no CNS effects of a single oral dose. | Psychopharmacology (Berl) | 1982 | https://conductscience.org/library/papers/6126894 | PubMed |
| 2,905,641 | Ocular metipranolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in glaucoma and ocular hypertension. | Drugs | 1988 | https://conductscience.org/library/papers/2905641 | PubMed |
| 2,858,433 | A study on the ocular and extraocular pharmacology of metipranolol. | Graefes Arch Clin Exp Ophthalmol | 1985 | https://conductscience.org/library/papers/2858433 | PubMed |
| 2,202,584 | Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension. | Drugs | 1990 | https://conductscience.org/library/papers/2202584 | PubMed |
| 214,719 | Identification and quantification of beta-adrenoceptors sites in red blood cells from rats. | Naunyn Schmiedebergs Arch Pharmacol | 1978 | https://conductscience.org/library/papers/214719 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18157
GET https://conductscience.org/api/papers/v1/18157/authors